NCT03404843View on ClinicalTrials.gov

Red Blood Cell ATP Release and Vascular Function in Humans

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

October 5, 2018

Study Completion Date

October 5, 2018

Conditions
Cardiovascular Diseases
Interventions
DRUG

Fasudil Hydrochloride

10 mg/mL vial of fasudil hydrochloride. 6 mL (60 mg) of fasudil hydrochloride are added to a 100 mL saline bag for delivery to subjects.

OTHER

Saline

100 mL saline bag.

Trial Locations (1)

80523

Colorado State University, Dept. of Health and Exercise Science, Fort Collins

All Listed Sponsors
lead

Colorado State University

OTHER

NCT03404843 - Red Blood Cell ATP Release and Vascular Function in Humans | Biotech Hunter | Biotech Hunter